
Study identifies new therapeutic target for glioblastoma
Scientists have demonstrated that glioblastoma (GBM) tumour stem cells became less able to proliferate and invade tissues when the production of the prion protein was blocked, highlighting a potential new therapeutic target. GBM, which accounts for nearly half (49%) of all brain tumours, has an extremely low… Read More



